Cellectis S.A. (LON:0WA2)
London · Delayed Price · Currency is GBP · Price in EUR 2.910
-0.180 (-5.83%)
At close: Nov 3, 2025
Cellectis Market Cap
Cellectis has a market cap or net worth of 185.26 million as of November 6, 2025. Its market cap has increased by 77.08% in one year.
Market Cap
185.26M
Enterprise Value
208.61M
Revenue
46.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.91
Market Cap Chart
Since February 7, 2007, Cellectis's market cap has increased from 66.49M to 185.26M, an increase of 178.61%. That is a compound annual growth rate of 5.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 185.26M | 91.00% |
| Dec 31, 2024 | 96.99M | -43.64% |
| Dec 29, 2023 | 172.10M | 114.24% |
| Dec 30, 2022 | 80.33M | -71.73% |
| Dec 31, 2021 | 284.18M | -69.41% |
| Dec 31, 2020 | 929.08M | 64.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.27B |
| HSBC Holdings | 184.59B |
| Shell | 164.07B |
| Unilever | 115.32B |
| Rolls-Royce Holdings | 96.56B |
| Rio Tinto Group | 90.02B |
| British American Tobacco p.l.c. | 88.16B |
| GSK plc | 71.94B |